Optimize Vancomycin Dose in Surgical Ward Patients with Augmented Renal Clearance Determined by Chronic Kidney Disease Epidemiology Collaboration Equation.

IF 2.9 3区 医学 Q2 INFECTIOUS DISEASES
Infection and Drug Resistance Pub Date : 2024-09-27 eCollection Date: 2024-01-01 DOI:10.2147/IDR.S477414
Li-Yu Chen, Chen-Yu Wang, Chi-Ying Lin, Ming-Jui Tsai, Wei-Hsun Shen, Pei-Jhih Li, Lin-Chu Liao, Chih-Fen Huang, Chien-Chih Wu
{"title":"Optimize Vancomycin Dose in Surgical Ward Patients with Augmented Renal Clearance Determined by Chronic Kidney Disease Epidemiology Collaboration Equation.","authors":"Li-Yu Chen, Chen-Yu Wang, Chi-Ying Lin, Ming-Jui Tsai, Wei-Hsun Shen, Pei-Jhih Li, Lin-Chu Liao, Chih-Fen Huang, Chien-Chih Wu","doi":"10.2147/IDR.S477414","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>In the field of postoperative care, infections caused by Gram-positive bacteria pose a major clinical challenge. Vancomycin is a key therapeutic agent whose efficacy is greatly influenced by renal function, particularly by augmented renal clearance (ARC). The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) estimated glomerular filtration rate (eGFR) is an easy and commonly used method to predict ARC; however, it is not well studied to determine vancomycin dose. In this study, we examined the effectiveness of the CKD-EPI equation in determining ARC and optimizing the dose of vancomycin for surgical ward patients.</p><p><strong>Methodology: </strong>A retrospective observational study was conducted to examine 158 surgical ward patients receiving vancomycin. Data on demographics, medical history, and vancomycin dosing were collected. Renal function was evaluated using the CKD-EPI equation, with ARC defined as eGFR ≥ 96.5 mL/min/1.73 m<sup>2</sup>. Vancomycin pharmacokinetics were calculated using the ClinCalc tool.</p><p><strong>Results: </strong>ARC was in 54% of the patients. Compared with patients without ARC, those with ARC were younger and had lower serum creatinine levels. They also required higher vancomycin doses but had lower trough concentrations and 24-hour area-under-the-curve values. A significant correlation was observed between eGFR and vancomycin clearance, with eGFR > 96.5 mL/min/1.73 m<sup>2</sup> necessitating higher vancomycin doses (>45 mg/kg/day) to achieve the desired area under the curve to minimum inhibitory concentration ratio.</p><p><strong>Conclusion: </strong>For surgical ward patients with CKD-EPI eGFR ≥ 96.5 mL/min/1.73 m<sup>2</sup>, a vancomycin dosage of >45 mg/kg/day may be recommended to reach effective therapeutic levels. Overall, this study emphasizes the importance of tailoring vancomycin therapy depending on renal function to ensure efficacy and mitigate the risk of antimicrobial resistance in surgical ward patients.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":"17 ","pages":"4195-4203"},"PeriodicalIF":2.9000,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11444064/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infection and Drug Resistance","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/IDR.S477414","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: In the field of postoperative care, infections caused by Gram-positive bacteria pose a major clinical challenge. Vancomycin is a key therapeutic agent whose efficacy is greatly influenced by renal function, particularly by augmented renal clearance (ARC). The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) estimated glomerular filtration rate (eGFR) is an easy and commonly used method to predict ARC; however, it is not well studied to determine vancomycin dose. In this study, we examined the effectiveness of the CKD-EPI equation in determining ARC and optimizing the dose of vancomycin for surgical ward patients.

Methodology: A retrospective observational study was conducted to examine 158 surgical ward patients receiving vancomycin. Data on demographics, medical history, and vancomycin dosing were collected. Renal function was evaluated using the CKD-EPI equation, with ARC defined as eGFR ≥ 96.5 mL/min/1.73 m2. Vancomycin pharmacokinetics were calculated using the ClinCalc tool.

Results: ARC was in 54% of the patients. Compared with patients without ARC, those with ARC were younger and had lower serum creatinine levels. They also required higher vancomycin doses but had lower trough concentrations and 24-hour area-under-the-curve values. A significant correlation was observed between eGFR and vancomycin clearance, with eGFR > 96.5 mL/min/1.73 m2 necessitating higher vancomycin doses (>45 mg/kg/day) to achieve the desired area under the curve to minimum inhibitory concentration ratio.

Conclusion: For surgical ward patients with CKD-EPI eGFR ≥ 96.5 mL/min/1.73 m2, a vancomycin dosage of >45 mg/kg/day may be recommended to reach effective therapeutic levels. Overall, this study emphasizes the importance of tailoring vancomycin therapy depending on renal function to ensure efficacy and mitigate the risk of antimicrobial resistance in surgical ward patients.

根据慢性肾脏病流行病学协作方程,优化肾清除率增高的外科病房患者的万古霉素剂量。
背景:在术后护理领域,革兰氏阳性细菌引起的感染是一项重大的临床挑战。万古霉素是一种重要的治疗药物,其疗效受肾功能影响很大,特别是受增强肾清除率(ARC)的影响。慢性肾脏病流行病学协作组(CKD-EPI)估算的肾小球滤过率(eGFR)是预测 ARC 的一种简便而常用的方法;但在确定万古霉素剂量方面,对它的研究并不充分。在本研究中,我们考察了 CKD-EPI 等式在确定 ARC 和优化外科病房患者万古霉素剂量方面的有效性:我们开展了一项回顾性观察研究,对 158 名接受万古霉素治疗的外科病房患者进行了调查。研究收集了有关人口统计学、病史和万古霉素剂量的数据。肾功能采用 CKD-EPI 公式进行评估,ARC 的定义为 eGFR ≥ 96.5 mL/min/1.73 m2。使用 ClinCalc 工具计算万古霉素药代动力学:54%的患者患有 ARC。与无 ARC 的患者相比,有 ARC 的患者更年轻,血清肌酐水平更低。他们所需的万古霉素剂量也较高,但谷浓度和 24 小时曲线下面积值较低。eGFR 与万古霉素清除率之间存在明显的相关性,eGFR > 96.5 mL/min/1.73 m2 时,万古霉素剂量需要更高(>45 mg/kg/天),以达到理想的曲线下面积与最低抑制浓度比值:结论:对于 CKD-EPI eGFR ≥ 96.5 mL/min/1.73 m2 的外科病房患者,建议万古霉素剂量大于 45 mg/kg/天,以达到有效的治疗水平。总之,本研究强调了根据肾功能调整万古霉素治疗的重要性,以确保疗效并降低外科病房患者产生抗菌素耐药性的风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Infection and Drug Resistance
Infection and Drug Resistance Medicine-Pharmacology (medical)
CiteScore
5.60
自引率
7.70%
发文量
826
审稿时长
16 weeks
期刊介绍: About Journal Editors Peer Reviewers Articles Article Publishing Charges Aims and Scope Call For Papers ISSN: 1178-6973 Editor-in-Chief: Professor Suresh Antony An international, peer-reviewed, open access journal that focuses on the optimal treatment of infection (bacterial, fungal and viral) and the development and institution of preventative strategies to minimize the development and spread of resistance.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信